Wikidata

(Q59640166)

English

Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation

scientific article published on 09 January 2012

In more languages
default for all languages
No label defined

No description defined

Statements

title
Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22225474
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22225474%20AND%20SRC:MED&resulttype=core&format=json
retrieved
19 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q59640166&oldid=2149215317"